Literature DB >> 18590648

[Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy].

Eduardo Alegría Ezquerra1, José M Castellano Vázquez, Ana Alegría Barrero.   

Abstract

Obesity, metabolic syndrome and type-2 diabetes mellitus are three interrelated conditions that share a number of pathophysiological mechanisms and that are frequently observed to lead, in succession, to cardiovascular complications. The fact that their prevalence is increasing alarmingly should prompt all healthcare professionals urgently to implement measures to prevent these complications. The most effective, though also the least adopted, are those related to lifestyle modification. Drug treatment targeted at controlling risk factors (e.g., hypertension, dyslipidemia, and thrombophilia), metabolic abnormalities, and excess weight is also necessary.

Entities:  

Mesh:

Year:  2008        PMID: 18590648

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  20 in total

1.  Tennis training sessions as a rehabilitation instrument for patients after acute myocardial infarction.

Authors:  Juan P F García; Víctor M A Giraldo; José J G Barrado; César D Casasola
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

2.  Homogeneous Assays of Second Messenger Signaling and Hormone Secretion Using Thermofluorimetric Methods That Minimize Calibration Burden.

Authors:  Juan Hu; Christopher J Easley
Journal:  Anal Chem       Date:  2017-07-25       Impact factor: 6.986

3.  Effects of laparoscopic Roux-en-Y gastric bypass (LRYGB) on weight loss and biomarker parameters in morbidly obese patients: a 12-month follow-up.

Authors:  Karamollah Toolabi; Saeed Arefanian; Mahdieh Golzarand; Hossein Arefanian
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 4.  Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome.

Authors:  Malvina Pizzuto; Pablo Pelegrin; Jean-Marie Ruysschaert
Journal:  Prog Lipid Res       Date:  2022-07-25       Impact factor: 14.673

5.  Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians.

Authors:  Walaa Arafa Keshk; Doaa Hussein Zineldeen; Rania E L-sayed Wasfy; Osama Helmy El-Khadrawy
Journal:  Med Oncol       Date:  2014-08-31       Impact factor: 3.064

6.  Plasma lipid levels of rats fed a diet containing pork fat as a source of lipids after splenic surgery.

Authors:  Ana Paula Gonçalves Dinis; Ruy Garcia Marques; Fernanda Correia Simões; Cristina Fajardo Diestel; Carlos Eduardo Rodrigues Caetano; Dióscuro José Ferreira Secchin; José Firmino Nogueira Neto; Margareth Crisóstomo Portela
Journal:  Lipids       Date:  2009-05-05       Impact factor: 1.880

7.  Investigation of relationship of visceral body fat and inflammatory markers with metabolic syndrome and its components among apparently healthy individuals.

Authors:  Yasemin Turker; Davut Baltaci; Yasin Turker; Serkan Ozturk; Cemil Isik Sonmez; Mehmet Harun Deler; Yunus Cem Sariguzel; Feyza Sariguzel; Handan Ankarali
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Parathyroid Hormone Levels May Predict Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Authors:  Morteza Ghoghaei; Foad Taghdiri; Elias Khajeh; Farid Azmoudeh Ardalan; Mojtaba Sedaghat; Sepideh Hosseini Shirvani; Shadi Zarei; Karamollah Toolabi
Journal:  Hepat Mon       Date:  2015-07-22       Impact factor: 0.660

9.  Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.

Authors:  Tatiana Dilla; Amparo Valladares; Claudia Nicolay; Javier Salvador; Jesús Reviriego; María Costi
Journal:  Appl Health Econ Health Policy       Date:  2012-11-01       Impact factor: 2.561

10.  Comparison of the Combined Obesity Indices to Predict Cardiovascular Diseases Risk Factors and Metabolic Syndrome in Northeast China.

Authors:  Yuchun Tao; Jianxing Yu; Yuhui Tao; Hui Pang; Yang Yu; Yaqin Yu; Lina Jin
Journal:  Int J Environ Res Public Health       Date:  2016-08-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.